Cargando…

The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization

The entry of the SARS coronavirus (SCV) into cells is initiated by binding of its spike envelope glycoprotein (S) to a receptor, ACE2. We and others identified the receptor-binding domain (RBD) by using S fragments of various lengths but all including the amino acid residue 318 and two other potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborti, Samitabh, Prabakaran, Ponraj, Xiao, Xiaodong, Dimitrov, Dimiter S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236967/ https://www.ncbi.nlm.nih.gov/pubmed/16122388 http://dx.doi.org/10.1186/1743-422X-2-73

Ejemplares similares

The SARS-CoV S glycoprotein: expression and functional characterization
por: Xiao, Xiaodong, et al.
Publicado: (2003)

Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
por: Xiao, Xiaodong, et al.
Publicado: (2004)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

A model of the ACE2 structure and function as a SARS-CoV receptor
por: Prabakaran, Ponraj, et al.
Publicado: (2004)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

454 antibody sequencing - error characterization and correction
por: Prabakaran, Ponraj, et al.
Publicado: (2011)

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
por: Xiao, Xiaodong, et al.
Publicado: (2009)

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
por: Chen, Weizao, et al.
Publicado: (2012)

Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity
por: Wan, Chao, et al.
Publicado: (2013)

Interactions of IgG1 CH2 and CH3 Domains with FcRn
por: Ying, Tianlei, et al.
Publicado: (2014)

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Structure of an isolated unglycosylated antibody C(H)2 domain
por: Prabakaran, Ponraj, et al.
Publicado: (2008)

Antibody Aggregation: Insights from Sequence and Structure
por: Li, Wei, et al.
Publicado: (2016)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
por: Zhu, Zhongyu, et al.
Publicado: (2013)

Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
por: Prabakaran, Ponraj, et al.
Publicado: (2012)

Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
por: Antonopoulos, Aristotelis, et al.
Publicado: (2020)

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011)

Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2
por: Fraguas Bringas, Conchita, et al.
Publicado: (2020)

Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry
por: Corver, Jeroen, et al.
Publicado: (2009)

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding
por: Mannar, Dhiraj, et al.
Publicado: (2021)

Fine epitope mapping of glycoprotein Gn in Guertu virus
por: Zhang, Jingyuan, et al.
Publicado: (2019)

The Secret Life of ACE2 as a Receptor for the SARS Virus
por: Dimitrov, Dimiter S
Publicado: (2003)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Kulkarni, Seema A., et al.
Publicado: (2021)

Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Rodríguez, Yoel, et al.
Publicado: (2022)

Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
por: Loo, Tip W., et al.
Publicado: (2015)

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
por: Chen, Weizao, et al.
Publicado: (2010)

Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020)

The SARS-CoV S glycoprotein
por: Xiao, X., et al.
Publicado: (2004)

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Protocol for constructing large size human antibody heavy chain variable domain (V(H)) library and selection of SARS-CoV-2 neutralizing antibody domains
por: Chen, Chuan, et al.
Publicado: (2021)

Editorial: Therapeutic antibody domains against cancer
por: Zhao, Qi, et al.
Publicado: (2023)

Landscape of Non-canonical Cysteines in Human V(H) Repertoire Revealed by Immunogenetic Analysis
por: Prabakaran, Ponraj, et al.
Publicado: (2020)

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
por: Azad, Taha, et al.
Publicado: (2020)

An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding
por: Cao, Guangcan, et al.
Publicado: (2019)

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
por: Wang, Lin, et al.
Publicado: (2020)

Proteolysis of Sars-Associated Coronavirus Spike Glycoprotein
por: Simmons, Graham, et al.
Publicado: (2006)

The “SARS-unique domain” (SUD) of SARS coronavirus is an oligo(G)-binding protein
por: Tan, Jinzhi, et al.
Publicado: (2007)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dam2gpv1brefibpt4mvkp4u252